S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
The Retirement of Your Dreams Awaits You… (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
The Retirement of Your Dreams Awaits You… (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
The Retirement of Your Dreams Awaits You… (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
The Retirement of Your Dreams Awaits You… (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
The Retirement of Your Dreams Awaits You… (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
The Retirement of Your Dreams Awaits You… (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
The Retirement of Your Dreams Awaits You… (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
The Retirement of Your Dreams Awaits You… (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
The Retirement of Your Dreams Awaits You… (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
The Retirement of Your Dreams Awaits You… (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
The Retirement of Your Dreams Awaits You… (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
The Retirement of Your Dreams Awaits You… (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
NASDAQ:IRMD

IRadimed (IRMD) Stock Price, News & Analysis

$42.39
+0.56 (+1.34%)
(As of 02/23/2024 ET)
Today's Range
$41.70
$44.08
50-Day Range
$41.41
$47.47
52-Week Range
$36.12
$51.04
Volume
73,400 shs
Average Volume
55,903 shs
Market Capitalization
$534.54 million
P/E Ratio
31.17
Dividend Yield
1.42%
Price Target
$60.00

IRadimed MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
41.5% Upside
$60.00 Price Target
Short Interest
Healthy
0.98% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.85mentions of IRadimed in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$889,453 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.86 out of 5 stars

Medical Sector

42nd out of 941 stocks

Surgical & Medical Instruments Industry

7th out of 90 stocks


IRMD stock logo

About IRadimed Stock (NASDAQ:IRMD)

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IRMD Stock Price History

IRMD Stock News Headlines

Should You Invest in IRadimed Corporation (IRMD)?
IRMD Mar 2024 45.000 put
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
IRMD Mar 2024 40.000 call
IRMD Feb 2024 44.520 call
New Trump Bombshell
I believe Donald J. Trump will go down as America’s last Republican president.  But NOT for the reasons you may think…  If I’m right, the soul of this country will change forever…
IRadimed: Q4 Earnings Snapshot
iRadimed's Earnings Outlook
iRadimed Q4 2023 Earnings Preview
Lake Street Reaffirms Their Buy Rating on Iradimed (IRMD)
Why We Like The Returns At IRadimed (NASDAQ:IRMD)
iRadimed Corp IRMD
5 Small Hidden Gems for the Rest of 2023
See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/28/2021
Ex-Dividend for 1/12 Dividend
12/21/2023
Dividend Payable
1/12/2024
Today
2/23/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IRMD
Employees
123
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.00
High Stock Price Target
$60.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+41.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$17.19 million
Pretax Margin
32.97%

Debt

Sales & Book Value

Annual Sales
$65.56 million
Cash Flow
$1.05 per share
Book Value
$5.86 per share

Miscellaneous

Free Float
7,238,000
Market Cap
$534.54 million
Optionable
Optionable
Beta
0.81
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Roger E. Susi (Age 71)
    Founder, Chairman, CEO & President
    Comp: $586.04k
  • Mr. John F. Glenn (Age 62)
    CFO & Corporate Secretary
    Comp: $411.79k
  • Mr. Randy Waddell
    Vice President of Worldwide Sales & Marketing
  • Mr. Steve Kachelmeyer
    Vice President of Regulatory Affairs & Quality Assurance
  • Mr. Lynn Neuhardt
    Vice President of Research & Development
  • Mr. Chris Williamson
    Executive Vice President of Continuous Improvement & Information Technology
  • Mr. Matt Garner
    Controller














IRMD Stock Analysis - Frequently Asked Questions

Should I buy or sell IRadimed stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings
or view top-rated stocks.

What is IRadimed's stock price target for 2024?

1 equities research analysts have issued 12 month target prices for IRadimed's stock. Their IRMD share price targets range from $60.00 to $60.00. On average, they predict the company's share price to reach $60.00 in the next year. This suggests a possible upside of 41.5% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2024?

IRadimed's stock was trading at $47.47 on January 1st, 2024. Since then, IRMD stock has decreased by 10.7% and is now trading at $42.39.
View the best growth stocks for 2024 here
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) issued its quarterly earnings results on Thursday, October, 28th. The medical equipment provider reported $0.23 EPS for the quarter, beating the consensus estimate of $0.17 by $0.06. The medical equipment provider earned $10.91 million during the quarter, compared to analysts' expectations of $10.39 million. IRadimed had a trailing twelve-month return on equity of 24.81% and a net margin of 26.22%. During the same quarter last year, the company posted $0.09 earnings per share.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed declared a -- dividend on Tuesday, December 12th. Investors of record on Friday, December 22nd will be paid a dividend of $0.15 per share on Friday, January 12th. The ex-dividend date of this dividend is Thursday, December 21st.
Read our dividend analysis for IRMD
.

Is IRadimed a good dividend stock?

IRadimed (NASDAQ:IRMD) pays an annual dividend of $0.60 per share and currently has a dividend yield of 1.39%. The dividend payout ratio is 44.12%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for IRMD.

What ETF holds IRadimed's stock ?

Ballast Small/Mid Cap ETF holds 19,404 shares of IRMD stock, representing 0.98% of its portfolio.

What guidance has IRadimed issued on next quarter's earnings?

IRadimed updated its first quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of 0.330-0.350 for the period, compared to the consensus estimate of 0.410. The company issued revenue guidance of $17.0 million-$17.3 million, compared to the consensus revenue estimate of $17.6 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

Who are IRadimed's major shareholders?

IRadimed's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.39%), RK Capital Management LLC (2.70%), Ranger Investment Management L.P. (1.77%), Russell Investments Group Ltd. (1.68%), Dimensional Fund Advisors LP (1.67%) and Resource Consulting Group Inc. (0.82%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRMD) was last updated on 2/24/2024 by MarketBeat.com Staff